Lydia Giles

1.3k total citations
10 papers, 342 citations indexed

About

Lydia Giles is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Lydia Giles has authored 10 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Lydia Giles's work include Cutaneous Melanoma Detection and Management (4 papers), Immunotherapy and Immune Responses (3 papers) and Melanoma and MAPK Pathways (3 papers). Lydia Giles is often cited by papers focused on Cutaneous Melanoma Detection and Management (4 papers), Immunotherapy and Immune Responses (3 papers) and Melanoma and MAPK Pathways (3 papers). Lydia Giles collaborates with scholars based in United States. Lydia Giles's co-authors include Ravi K. Amaravadi, Lynn M. Schuchter, Suzanne McGettigan, Leslie A. Fecher, Karolyn A. Wanat, Christopher J. Miller, Misha Rosenbach, John T. Seykora, Marcia S. Brose and Emily Y. Chu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Lydia Giles

10 papers receiving 336 citations

Peers

Countries citing papers authored by Lydia Giles

Since Specialization

Citations

This map shows the geographic impact of Lydia Giles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Giles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Giles more than expected).

Fields of papers citing papers by Lydia Giles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lydia Giles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Giles. The network helps show where Lydia Giles may publish in the future.

Co-authorship network of co-authors of Lydia Giles

This figure shows the co-authorship network connecting the top 25 collaborators of Lydia Giles. A scholar is included among the top collaborators of Lydia Giles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lydia Giles. Lydia Giles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Partner-developed electronic health record tools to facilitate social risk-informed care planning 2023 ·Journal of the American Medical Informatics Association ·Rose Gunn, Maura Pisciotta, Rachel Gold, Arwen Bunce, Katie Dambrun, Erika Cottrell, Danielle Hessler, Mary Middendorf, Miguel A. Álvarez, Lydia Giles, Laura M. Gottlieb	6
2	Landmark analysis of immunotherapy duration and disease free survival in advanced melanoma patients with a complete response. 2020 ·Journal of Clinical Oncology ·(unknown), Alexander C. Huang, Giorgos C. Karakousis, Wei Xu, Cathy Zheng, Mary Carberry, Lydia Giles, Kristin Kreider, Suzanne McGettigan, John N. Lukens, Lynn M. Schuchter, Ravi K. Amaravadi, Tara C. Mitchell	2
3	Abstract CT181: Safety, activity, and biomarkers for neoadjuvant anti-PD-1 therapy in melanoma 2018 ·Cancer Research ·Alexander C. Huang, (unknown), Robert Orlowski, Sangeeth M. George, Lakshmi Chilukuri, Andrew Kozlov, Mary Carberry, Lydia Giles, Suzanne McGettigan, Kristin Kreider, Jennifer H. Yearley, Lakshmanan Annamalai, Gerald P. Linette, Ravi K. Amaravadi, Lynn M. Schuchter, Michael D. Farwell, (unknown), Giorgos C. Karakousis, Tara C. Gangadhar	7
4	Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study 2012 ·Journal of the American Academy of Dermatology ·Emily Y. Chu, Karolyn A. Wanat, Christopher J. Miller, Ravi K. Amaravadi, Leslie A. Fecher, Marcia S. Brose, Suzanne McGettigan, Lydia Giles, Lynn M. Schuchter, John T. Seykora, Misha Rosenbach	128
5	Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases 2009 ·Clinical Cancer Research ·Ravi K. Amaravadi, Lynn M. Schuchter, David F. McDermott, Amy Kramer, Lydia Giles, Kristi Gramlich, Mary Carberry, Andrea B. Troxel, Richard Letrero, Katherine L. Nathanson, Michael B. Atkins, Peter J. O’Dwyer, Keith T. Flaherty	89
6	Phase I/II trial of imatinib and temozolomide in advanced unresectable melanoma 2008 ·Journal of Clinical Oncology ·Leslie A. Fecher, (unknown), Keith T. Flaherty, Ravi K. Amaravadi, Lydia Giles, Suzanne McGettigan, Mary Carberry, D Elder, Lynn M. Schuchter	5
7	Updated results of a randomized phase II study comparing two schedules of temozolomide in combination with sorafenib in patients with advanced melanoma 2007 ·Journal of Clinical Oncology ·Ravi K. Amaravadi, (unknown), David F. McDermott, Amy Kramer, Lydia Giles, Andrea B. Troxel, Calvo Medina, Katherine L. Nathanson, P J O'Dwyer, K. T. Flaherty	26
8	Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture 2006 ·Cancer Immunology Immunotherapy ·Klára Berencsi, Neal J. Meropol, John P. Hoffman, Elin R. Sigurdson, Lydia Giles, (unknown), Rajasekharan Somasundaram, Tianqian Zhang, Jiří Kalabis, Laura Caputo, Emma E. Furth, Rolf Swoboda, Francesco M. Marincola, Dorothee Herlyn	21
9	The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer 2005 ·The American Journal of Surgery ·Philip S. Mullenix, Tommy A. Brown, (unknown), Lydia Giles, Elin R. Sigurdson, Marcia Boraas, John P. Hoffman, Burton Eisenberg, Michael H. Torosian	16
10	Radiofrequency Ablation of Primary Lung Cancer 2005 ·CHEST Journal ·Christophe Nguyen, Walter J. Scott, Nancy A. Young, (unknown), Lydia Giles, Melvyn Goldberg	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact